Related Experiment Video
Updated: Dec 21, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Emerging role of mRNA epitranscriptomic regulation in chemoresistant cancer cells
1Inserm U981, Gustave Roussy Cancer Campus, Villejuif, France.
Abstract:
Cancer persister cells remain a significant barrier to effective anti-cancer therapy. We found that melanoma persister cells undergo a reversible reprogramming of mRNA translation. A subset of mRNAs, harboring N6-methyladenosine in their 5'-untranslated regions, is translationally up-regulated in an eIF4A-dependent manner. Targeting eIF4A prevents the emergence of resistant clones.
Insights
Cancer persister cells can be overcome by targeting mRNA translation. Melanoma cells reprogram translation via N6-methyladenosine modification, which can be blocked by targeting eIF4A to prevent resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cancer persister cells pose a significant challenge to current anti-cancer therapies.
- Understanding the mechanisms of persister cell survival is crucial for developing more effective treatments.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the survival of melanoma persister cells.
- To identify potential therapeutic targets to overcome treatment resistance.
Main Methods:
- Analysis of mRNA translation reprogramming in melanoma persister cells.
- Investigating the role of N6-methyladenosine (m6A) modification in 5'-untranslated regions of mRNAs.
- Assessing the impact of targeting eukaryotic initiation factor 4A (eIF4A) on persister cell emergence.
Main Results:
- Melanoma persister cells exhibit a reversible reprogramming of mRNA translation.
- A subset of mRNAs with m6A in their 5'-untranslated regions shows increased translation.
- Upregulation of translation is dependent on eIF4A activity.
Conclusions:
- Targeting eIF4A can prevent the emergence of drug-resistant melanoma clones.
- Modulation of mRNA translation and m6A modification represents a promising strategy against cancer persister cells.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
Treatment Resistant Cancers
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Regulation of Expression at Multiple Steps
MicroRNAs
MicroRNAs